Silence Therapeutics PLC
Ownership
Ownership Structure
Who owns Silence Therapeutics PLC (SLN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 60.9% of the shares are freely tradable; institutional investors hold 44.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Siren, L.L.C. | 5.33 | 3,311,438 | +13.7 | 06/30/2026 |
| TCG Crossover Management, LLC | 4.88 | 3,033,560 | +0.0 | 06/30/2026 |
| Nantahala Capital Management, LLC | 4.33 | 2,693,462 | +25.5 | 06/30/2026 |
| Redmile Group, LLC | 3.48 | 2,164,777 | +0.0 | 06/30/2026 |
| Citadel Advisors Llc | 2.14 | 1,329,625 | +7.7 | 06/30/2026 |
| Nextech Invest, Ltd. | 1.53 | 952,400 | +0.0 | 06/30/2026 |
| Millennium Management LLC | 1.46 | 909,279 | -15.4 | 06/30/2026 |
| Ikarian Capital, LLC | 1.34 | 830,784 | -4.0 | 06/30/2026 |
| Polygon Management Ltd | 1.23 | 764,256 | +21.3 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Select Biotechnology | 1.09 | 2,042,900 | +1,866.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.